Evidence map›Paper›PMID 40265387›Full record

Observational studyMedical sciences (Basel, Switzerland)2025

Role of IL-2, IL-6, and TNF-α as Potential Biomarkers in Ischemic Heart Disease: A Comparative Study of Patients with CAD and Non-CAD.

Ahmed E Altyar, Shilpa Bhardwaj, Nehmat Ghaboura, Priya Kaushik, Sattam Khulaif Alenezi, Mohammed Jaffar Sadiq Mantargi, Muhammad Afzal

Abstract readComparative StudyObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Medical sciences (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ahmed E AltyarDepartment of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, P.O. Box 80260, Jeddah 21589, Saudi Arabia.ORCID 0000-0001-6210-3628
Shilpa BhardwajDepartment of Neurochemistry, Institute of Human Behaviour and Allied Sciences Hospital, Delhi 110095, India.
Nehmat GhabouraPharmacy Program, Department of Pharmacy Practice, Batterjee Medical College, P.O. Box 6231, Jeddah 21442, Saudi Arabia.ORCID 0000-0002-0785-4135
Priya KaushikPacific Institute of Medical Sciences, Udaipur 313015, India.
Sattam Khulaif AleneziDepartment of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia.ORCID 0000-0002-4988-9838
Mohammed Jaffar Sadiq MantargiPharmacy Program, Department of Pharmaceutical Sciences, Batterjee Medical College, P.O. Box 6231, Jeddah 21442, Saudi Arabia.ORCID 0000-0002-3719-6241
Muhammad AfzalPharmacy Program, Department of Pharmaceutical Sciences, Batterjee Medical College, P.O. Box 6231, Jeddah 21442, Saudi Arabia.ORCID 0000-0003-2570-3223

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Coronary Artery DiseaseInterleukin-2Interleukin-6Myocardial IschemiaTumor Necrosis Factor-alphaAgedBiomarkersFemaleHumansMaleMiddle AgedProspective StudiesBiomarkersIL2 protein, humanIL6 protein, humanInterleukin-2Interleukin-6Tumor Necrosis Factor-alphacoronary artery diseasecytokinesinflammationischemic heart disease

Identifiers

PMID40265387
PMCPMC12015866

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.